Pediatrix Medical Group, Inc. MD delivered steady growth in the second quarter of 2026 despite continued pressure on patient volumes. Net revenues increased 4% year over year to $487.8 million, supported by recent acquisitions and higher same-unit revenues. In the second quarter, same-unit revenues from net reimbursement-related factors rose 4% year over year, offsetting a 2.1% decline in same-unit revenues attributable to patient volume.
Better reimbursement trends remained a key support. Improved RCM cash collections, a favorable payor mix and higher patient acuity, primarily in neonatology, helped lift same-unit pricing. Commercial and other non-government payor mix improved 135 basis points in the second quarter of 2026 from the year-ago period, while adjusted EBITDA increased to $76.4 million from $73.2 million.
Volume trends, however, could remain a constraint. The company expects full-year patient volumes to be roughly flat to slightly lower, consistent with past seasonal patterns. The benefit from stronger revenue-cycle collections is also expected to ease in the second half of 2026. Meanwhile, higher salaries and malpractice expenses could continue to weigh on operating leverage.
MD is expanding telehybrid services across women’s and children’s care and continues to evaluate acquisitions and partnership opportunities. The company also reaffirmed its 2026 adjusted EBITDA outlook of $280-$300 million. Overall, continued acuity gains, favorable payor mix and strategic expansion could support growth, but weaker volumes and easing collection benefits remain key risks.
How Are Peers Faring?
Some of MD’s peers in the medical space are Tenet Healthcare Corporation THC and HCA Healthcare, Inc. HCA.
Tenet Healthcare is benefiting from stronger hospital activity and higher-acuity care. In the second quarter of 2026, hospital unit’s net operating revenues increased 6% year over year, while admissions rose 2.3%. Higher acuity and service intensity are supporting revenue growth, alongside continued expansion of its ambulatory care business.
HCA Healthcare is seeing steady demand across its hospital network. In the second quarter of 2026, admissions increased 2.4%, while revenue per equivalent admission rose 6% year over year. Higher revenue intensity and Medicaid supplemental payments contributed to growth, with emergency-room visits also increasing during the quarter.
MD’s Price Performance, Valuation & Estimates
Shares of MD have gained 56.3% over the past year compared with the industry’s growth of 12.6%.
Image Source: Zacks Investment Research
From a valuation standpoint, Pediatrix trades at a forward price-to-earnings ratio of 11.63, below the industry average of 16.44. MD carries a Value Score of A.
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for Pediatrix’s 2026 earnings is pegged at $2.32 per share, implying 13.7% growth from the year-ago period.
Image Source: Zacks Investment Research
MD stock currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Radical New Technology Could Hand Investors Huge Gains
Quantum Computing is the next technological revolution, and it could be even more advanced than AI.
While some believed the technology was years away, it is already present and moving fast. Large hyperscalers, such as Microsoft, Google, Amazon, Oracle, and even Meta and Tesla, are scrambling to integrate quantum computing into their infrastructure.
Senior Stock Strategist Kevin Cook reveals 7 carefully selected stocks poised to dominate the quantum computing landscape in his report, Beyond AI: The Quantum Leap in Computing Power .
Kevin was among the early experts who recognized NVIDIA's enormous potential back in 2016. Now, he has keyed in on what could be "the next big thing" in quantum computing supremacy. Today, you have a rare chance to position your portfolio at the forefront of this opportunity.
See Top Quantum Stocks Now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Pediatrix Medical Group, Inc. (MD): Free Stock Analysis Report
Tenet Healthcare Corporation (THC): Free Stock Analysis Report
HCA Healthcare, Inc. (HCA): Free Stock Analysis Report
This article originally published on Zacks Investment Research (zacks.com).